12/16
02:00 pm
ardx
Ardelyx, Inc. (NASDAQ:ARDX): Is Breakeven Near? [Yahoo! Finance]
Low
Report
Ardelyx, Inc. (NASDAQ:ARDX): Is Breakeven Near? [Yahoo! Finance]
11/20
08:00 am
ardx
Ardelyx to Participate at the Piper Sandler 36th Annual Healthcare Conference
Medium
Report
Ardelyx to Participate at the Piper Sandler 36th Annual Healthcare Conference
11/11
02:45 pm
ardx
Ardelyx down as H.C. Wainwright downgrades rating on anticipated Xphozah sales drop [Seeking Alpha]
Low
Report
Ardelyx down as H.C. Wainwright downgrades rating on anticipated Xphozah sales drop [Seeking Alpha]
11/11
07:32 am
ardx
Ardelyx, Inc. (NASDAQ: ARDX) was downgraded by analysts at HC Wainwright from a "buy" rating to a "neutral" rating. They now have a $5.50 price target on the stock, down previously from $11.00.
Low
Report
Ardelyx, Inc. (NASDAQ: ARDX) was downgraded by analysts at HC Wainwright from a "buy" rating to a "neutral" rating. They now have a $5.50 price target on the stock, down previously from $11.00.
11/8
12:49 pm
ardx
Ardelyx Responds to District Court Decision Granting Motion to Dismiss [Yahoo! Finance]
Low
Report
Ardelyx Responds to District Court Decision Granting Motion to Dismiss [Yahoo! Finance]
11/8
12:31 pm
ardx
Ardelyx Responds to District Court Decision Granting Motion to Dismiss
Low
Report
Ardelyx Responds to District Court Decision Granting Motion to Dismiss
11/5
08:00 am
ardx
Ardelyx to Participate at the 2024 Jefferies London Healthcare Conference
Medium
Report
Ardelyx to Participate at the 2024 Jefferies London Healthcare Conference
11/4
12:44 pm
ardx
Ardelyx, Inc. (NASDAQ: ARDX) had its price target lowered by analysts at Citigroup Inc. from $12.00 to $10.00. They now have a "buy" rating on the stock.
Low
Report
Ardelyx, Inc. (NASDAQ: ARDX) had its price target lowered by analysts at Citigroup Inc. from $12.00 to $10.00. They now have a "buy" rating on the stock.
11/1
04:19 pm
ardx
Ardelyx, Inc. (NASDAQ: ARDX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $11.00 price target on the stock.
Low
Report
Ardelyx, Inc. (NASDAQ: ARDX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $11.00 price target on the stock.
10/31
08:35 pm
ardx
Ardelyx: Q3 Earnings Snapshot [Yahoo! Finance]
Low
Report
Ardelyx: Q3 Earnings Snapshot [Yahoo! Finance]
10/31
04:06 pm
ardx
Ardelyx Reports Third Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
Ardelyx Reports Third Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
10/31
04:02 pm
ardx
Ardelyx Reports Third Quarter 2024 Financial Results and Provides Business Update
Low
Report
Ardelyx Reports Third Quarter 2024 Financial Results and Provides Business Update
10/28
04:05 pm
ardx
Ardelyx Presents Results from its IBS in America 2024 Supplemental Survey at the American College of Gastroenterology’s (ACG) Annual Meeting
Low
Report
Ardelyx Presents Results from its IBS in America 2024 Supplemental Survey at the American College of Gastroenterology’s (ACG) Annual Meeting
10/24
04:05 pm
ardx
Ardelyx Shares Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) at the American Society of Nephrology’s Kidney Week
Low
Report
Ardelyx Shares Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) at the American Society of Nephrology’s Kidney Week
10/22
09:00 pm
ardx
ARDELYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Ardelyx, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Medium
Report
ARDELYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Ardelyx, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
10/22
04:05 pm
ardx
Ardelyx Announces Launch of Gut Matters: Discoveries and Innovations, a New Podcast for the IBS-C Patient Community
Medium
Report
Ardelyx Announces Launch of Gut Matters: Discoveries and Innovations, a New Podcast for the IBS-C Patient Community
10/21
04:05 pm
ardx
Ardelyx Announces the Derek Forfang Patient Advocate Award to Recognize Advocates for the Chronic Kidney Disease Community
Low
Report
Ardelyx Announces the Derek Forfang Patient Advocate Award to Recognize Advocates for the Chronic Kidney Disease Community
10/17
08:00 am
ardx
Ardelyx to Report Third Quarter 2024 Financial Results on October 31, 2024
Low
Report
Ardelyx to Report Third Quarter 2024 Financial Results on October 31, 2024
10/15
04:30 pm
ardx
Shareholders that lost money on Ardelyx, Inc.(ARDX) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More
Low
Report
Shareholders that lost money on Ardelyx, Inc.(ARDX) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More
10/15
11:15 am
ardx
Ardelyx, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before October 15, 2024 to Discuss Your Rights - ARDX
Low
Report
Ardelyx, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before October 15, 2024 to Discuss Your Rights - ARDX
10/15
10:45 am
ardx
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ardelyx, Inc. of Class Action Lawsuit and Upcoming Deadlines - ARDX
Low
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ardelyx, Inc. of Class Action Lawsuit and Upcoming Deadlines - ARDX
10/15
10:08 am
ardx
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardelyx
Low
Report
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardelyx
10/15
08:00 am
ardx
Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the American Society of Nephrology’s Kidney Week
Low
Report
Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the American Society of Nephrology’s Kidney Week
10/15
07:15 am
ardx
Investors who lost money on Ardelyx, Inc.(ARDX) should contact Levi & Korsinsky about pending Class Action - ARDX
Low
Report
Investors who lost money on Ardelyx, Inc.(ARDX) should contact Levi & Korsinsky about pending Class Action - ARDX
10/15
07:00 am
ardx
FINAL ARDX DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Ardelyx, Inc. Investors to Join the Class Action Lawsuit!
Low
Report
FINAL ARDX DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Ardelyx, Inc. Investors to Join the Class Action Lawsuit!